DaVita (NYSE: DVA) Beats Q1 Estimates, Reaffirms 2025 Guidance Amid Steady Operational Trends
DaVita (NYSE: DVA) reported first-quarter 2025 results that came in slightly ahead of Wall Street estimates, supported by steady treatment […]
DaVita (NYSE: DVA) reported first-quarter 2025 results that came in slightly ahead of Wall Street estimates, supported by steady treatment […]